Withania somnifera as a potential future drug molecule for COVID-19

References

• Johns Hopkins Coronavirus Research Center. COVID-19 map FAQ (2020). https://coronavirus.jhu.edu/map-faq
   Google Scholar
• TranK, CimonK, SevernM, Pessoa-SilvaCL, ConlyJ. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS ONE7(4), e35797–e35797 (2012).
   PubMed Web of Science ®Google Scholar
• clinicaltrials.gov. COVID-19 clinical trials search (2020). https://clinicaltrials.gov/ct2/results?cond=COVID-19
   Google Scholar
• VellingiriB, JayaramayyaK, IyerM et al.COVID-19: a promising cure for the global panic. Sci. Total Environ.725, 138277 (2020).
   PubMed Web of Science ®Google Scholar
• KumarA, ChoudhirG, ShuklaSK et al.Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. J. Biomol. Struct. Dyn.doi:10.1080/07391102.2020.1772112 (2020) ( Epub ahead of print).
   Google Scholar
• KumarA, ChoudhirG, ShuklaSK et al.Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. J. Biomol. Struct. Dyn.doi:10.1080/07391102.2020.1772112 (2020) ( Epub ahead of print).
   Google Scholar
• MandlikIngawale DS, NamdeoAG. Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects. J. Diet. Suppl.doi:10.1080/19390211.2020.1741484 (2020) ( Epub ahead of print).
   Web of Science ®Google Scholar
• MachiahDK, GowdaTV. Purification of a post-synaptic neurotoxic phospholipase A2 from Naja naja venom and its inhibition by a glycoprotein from Withania somnifera. Biochimie88(6), 701–710 (2006).
   PubMed Web of Science ®Google Scholar
• TandonN, YadavSS. Safety and clinical effectiveness of Withania Somnifera (Linn.) Dunal root in human ailments. J. Ethnopharmacol.255, 112768 (2020).
   PubMed Web of Science ®Google Scholar
• MirjaliliMH, MoyanoE, BonfillM, CusidoRM, PalazónJ. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules14(7), 2373–2393 (2009).
   PubMed Web of Science ®Google Scholar
• ZumlaA, ChanJF, AzharEI, HuiDS, YuenKY. Coronaviruses - drug discovery and therapeutic options. Nat. Rev. Drug Discov.15(5), 327–347 (2016).
   PubMed Web of Science ®Google Scholar
• KumarV, DhanjalJK, KaulSC, WadhwaR, SundarD. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M(pro)) of SARS-CoV-2 and inhibit its activity. J. Biomol. Struct. Dyn.doi:10.1080/07391102.2020.1772108 (2020) ( Epub ahead of print).
   Web of Science ®Google Scholar
• StraughnAR, KakarSS. Withaferin A: a potential therapeutic agent against COVID-19 infection. J. Ovarian Res.13(1), 79–79 (2020).
   PubMed Web of Science ®Google Scholar
• TripathiMK, SinghP, SharmaS, SinghTP, EthayathullaAS, KaurP. Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. J. Biomol. Struct. Dyn.doi:10.1080/07391102.2020.1790425 (2020) ( Epub ahead of print).
   Web of Science ®Google Scholar
• BalkrishnaA, PokhrelS, SinghJ, VarshneyA. Withanone from Withania somnifera may inhibit novel coronavirus (COVID-19) entry by disrupting interactions between viral S-protein receptor binding domain and host ACE2 receptor. Res. Square (Preprint)doi:10.21203/rs.3.rs-17806/v1 (2020) ( Epub ahead of print).
   Google Scholar
• LeungJM, YangCX, SinDD. COVID-19 and nicotine as a mediator of ACE-2. Eur. Respir. J.55(6), 2001261 (2020).
   PubMed Web of Science ®Google Scholar
• RemyaC, DileepKV, VariayrEJ, SadasivanC. An in silico guided identification of nAChR agonists from Withania somnifera. Front. Life Sci.9(3), 201–213 (2016).
   Web of Science ®Google Scholar
• The Print. Ashwagandha the new HCQ? Modi govt begins study to see if herb keeps coronavirus away (2020). https://theprint.in/health/ashwagandha-the-new-hcq-modi-govt-begins-study-to-see-if-herb-keeps-coronavirus-away/421830/
   Google Scholar
• ZhouP, YangXL, WangXG et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature579(7798), 270–273 (2020).
   PubMed Web of Science ®Google Scholar
• KumarV, DhanjalJK, BhargavaP et al.Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. J. Biomol. Struct. Dyn.doi:10.1080/07391102.2020.1775704 (2020) ( Epub ahead of print).
   Web of Science ®Google Scholar
• ChikhaleRV, GuravSS, PatilRB et al.SARS-CoV-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. J. Biomol. Struct. Dyn.doi:10.1080/07391102.2020.1778539 (2020) ( Epub ahead of print).
   Google Scholar
• CatanzaroM, FagianiF, RacchiM, CorsiniE, GovoniS, LanniC. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct. Target. Ther.5(1), 84 (2020).
   PubMed Web of Science ®Google Scholar
• CaiH. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir. Med.8(4), e20 (2020).
   PubMed Web of Science ®Google Scholar
• ScottonCJ, ChambersRC. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest132(4), 1311–1321 (2007).
   PubMed Web of Science ®Google Scholar
• BaleS, VenkateshP, SunkojuM, GoduguC. An adaptogen: Withaferin A ameliorates in vitro and in vivo pulmonary fibrosis by modulating the interplay of fibrotic, matricelluar proteins, and cytokines. Front. Pharmacol.9, 248 (2018).
   PubMed Web of Science ®Google Scholar
• Grunz-BorgmannE, MossineV, FritscheK, ParrishAR. Ashwagandha attenuates TNF-α- and LPS-induced NF-κB activation and CCL2 and CCL5 gene expression in NRK-52E cells. BMC Complement. Altern. Med.15, 434 (2015).
   PubMed Web of Science ®Google Scholar
• ImaiY, KubaK, NeelyGG et al.Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell133(2), 235–249 (2008).
   PubMed Web of Science ®Google Scholar
• QureshiSA, JahanM, LateefT, AhmedD, RaisS, AzmiMB. Presence of gallic acid and rutin improve the hepatoprotective strength of Withania coagulans. Pak. J. Pharm. Sci.32(Suppl. 1), 301–308 (2019).
   PubMed Web of Science ®Google Scholar
• AhmadH, AryaA, AgrawalS et al.Phospholipid complexation of NMITLI118RT+: way to a prudent therapeutic approach for beneficial outcomes in ischemic stroke in rats. Drug Deliv.23(9), 3606–3618 (2016).
   PubMed Web of Science ®Google Scholar
• MalaikozhundanB, VinodhiniJ, KalanjiamMAR et al.High synergistic antibacterial, antibiofilm, antidiabetic and antimetabolic activity of Withania somnifera leaf extract-assisted zinc oxide nanoparticle. Bioprocess. Biosyst. Eng.43, 1533–1547 (2020).
   PubMed Web of Science ®Google Scholar
• AhmadH, KhandelwalK, SamuelSS et al.Neuro-protective potential of a vesicular system of a standardized extract of a new chemotype of Withania somnifera Dunal (NMITLI118RT+) against cerebral stroke in rats. Drug Deliv.23(7), 2630–2641 (2016).
   PubMed Web of Science ®Google Scholar
• PiresA, FortunaA, AlvesG, FalcãoA. Intranasal drug delivery: how, why and what for?J. Pharm. Pharm. Sci.12(3), 288–311 (2009).
   PubMed Web of Science ®Google Scholar
• MukherjeeS, KumarG, PatnaikR. Withanolide a penetrates brain via intra-nasal administration and exerts neuroprotection in cerebral ischemia reperfusion injury in mice. Xenobiotica50(8), 957–966 (2020).
   PubMed Web of Science ®Google Scholar